Issued Patents 2019
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10413539 | Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132) | David M. Goldenberg | 2019-09-17 |
| 10322193 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2019-06-18 |
| 10280220 | Immunoconjugates with an intracellularly-cleavable linkage | — | 2019-05-07 |
| 10266605 | Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors | David M. Goldenberg | 2019-04-23 |
| 10265414 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2019-04-23 |
| 10206918 | Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers | Thomas M. Cardillo, David M. Goldenberg | 2019-02-19 |
| 10179171 | RS7 antibodies | Zhengxing Qu, Hans J. Hansen, David M. Goldenberg | 2019-01-15 |